Pacira BioSciences to Review Activist Investor's Proposed Board Nominees

Dow Jones

03/12

By Kelly Cloonan

Pacira BioSciences said its board would review the nominees proposed by activist investor Doma Perpetual Capital Management.

Pacira confirmed Wednesday that Doma nominated three director candidates to stand for election to its board at its annual meeting of shareholders.

Doma had said earlier Wednesday its nominees include Christopher Dennis, a physician executive and board-certified psychiatrist; Oliver Benton Curtis III, a former federal prosecutor and trial lawyer; and Eric de Armas, Doma's finance chief and chief compliance officer.

Pacira said it has met with Doma 12 times since Frank Lee became its chief executive officer in 2024. It said Doma has not provided new insights regarding Pacira's strategy that it has not already evaluated or executed.

Doma said Pacira has underserved its shareholders by raising management compensation and recording higher expenses as the stock has declined. Doma also called for the replacement of Pacira's CEO.

Pacira said its plans have the backing of its majority shareholders.

"In our regular conversations with Pacira shareholders representing a majority of outstanding shares, we have heard clear support for our growth strategy," Pacira said.

Write to Kelly Cloonan at kelly.cloonan@wsj.com

(END) Dow Jones Newswires

March 11, 2026 17:43 ET (21:43 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2618597999"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2618597999\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2618597999?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-12 05:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618597999","market":"nz","top_or_hot":-1,"title":"Pacira BioSciences to Review Activist Investor's Proposed Board Nominees","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Kelly Cloonan \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Pacira BioSciences said its board would review the nominees proposed by activist investor Doma Perpetual Capital Management. \n</p>\n<p>\n  Pacira confirmed Wednesday that Doma nominated three director candidates to stand for election to its board at its annual meeting of shareholders. \n</p>\n<p>\n  Doma had said earlier Wednesday its nominees include Christopher Dennis, a physician executive and board-certified psychiatrist; Oliver Benton Curtis III, a former federal prosecutor and trial lawyer; and Eric de Armas, Doma's finance chief and chief compliance officer. \n</p>\n<p>\n  Pacira said it has met with Doma 12 times since Frank Lee became its chief executive officer in 2024. It said Doma has not provided new insights regarding Pacira's strategy that it has not already evaluated or executed. \n</p>\n<p>\n  Doma said Pacira has underserved its shareholders by raising management compensation and recording higher expenses as the stock has declined. Doma also called for the replacement of Pacira's CEO. \n</p>\n<p>\n  Pacira said its plans have the backing of its majority shareholders. \n</p>\n<p>\n  \"In our regular conversations with Pacira shareholders representing a majority of outstanding shares, we have heard clear support for our growth strategy,\" Pacira said. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 11, 2026 17:43 ET (21:43 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pacira BioSciences to Review Activist Investor's Proposed Board Nominees</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPacira BioSciences to Review Activist Investor's Proposed Board Nominees\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2026-03-12 05:43</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Kelly Cloonan \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Pacira BioSciences said its board would review the nominees proposed by activist investor Doma Perpetual Capital Management. \n</p>\n<p>\n  Pacira confirmed Wednesday that Doma nominated three director candidates to stand for election to its board at its annual meeting of shareholders. \n</p>\n<p>\n  Doma had said earlier Wednesday its nominees include Christopher Dennis, a physician executive and board-certified psychiatrist; Oliver Benton Curtis III, a former federal prosecutor and trial lawyer; and Eric de Armas, Doma's finance chief and chief compliance officer. \n</p>\n<p>\n  Pacira said it has met with Doma 12 times since Frank Lee became its chief executive officer in 2024. It said Doma has not provided new insights regarding Pacira's strategy that it has not already evaluated or executed. \n</p>\n<p>\n  Doma said Pacira has underserved its shareholders by raising management compensation and recording higher expenses as the stock has declined. Doma also called for the replacement of Pacira's CEO. \n</p>\n<p>\n  Pacira said its plans have the backing of its majority shareholders. \n</p>\n<p>\n  \"In our regular conversations with Pacira shareholders representing a majority of outstanding shares, we have heard clear support for our growth strategy,\" Pacira said. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 11, 2026 17:43 ET (21:43 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"製藥","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2618597999","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618597999","pubTimestamp":1773265380,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Pacira BioSciences said its board would review the nominees proposed by activist investor Doma Perpetual Capital Management.Pacira confirmed Wednesday that Doma nominated three director candidates to stand for election to its board at its annual meeting of shareholders.Doma had said earlier Wednesday its nominees include Christopher Dennis, a physician executive and board-certified psychiatrist; Oliver Benton Curtis III, a former federal prosecutor and trial lawyer; and Eric de Armas, Doma's finance chief and chief compliance officer.Pacira said it has met with Doma 12 times since Frank Lee became its chief executive officer in 2024. It said Doma has not provided new insights regarding Pacira's strategy that it has not already evaluated or executed.Doma said Pacira has underserved its shareholders by raising management compensation and recording higher expenses as the stock has declined. Doma also called for the replacement of Pacira's CEO.Pacira said its plans have the backing of its ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","PCRX":"Pacira Pharmaceuticals"},"translate_title":"Pacira BioSciences将审查激进投资者提出的董事会提名人","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PCRX":0.9},"content_text":"By Kelly Cloonan \n\n\n \n\n\n  Pacira BioSciences said its board would review the nominees proposed by activist investor Doma Perpetual Capital Management. \n\n\n  Pacira confirmed Wednesday that Doma nominated three director candidates to stand for election to its board at its annual meeting of shareholders. \n\n\n  Doma had said earlier Wednesday its nominees include Christopher Dennis, a physician executive and board-certified psychiatrist; Oliver Benton Curtis III, a former federal prosecutor and trial lawyer; and Eric de Armas, Doma's finance chief and chief compliance officer. \n\n\n  Pacira said it has met with Doma 12 times since Frank Lee became its chief executive officer in 2024. It said Doma has not provided new insights regarding Pacira's strategy that it has not already evaluated or executed. \n\n\n  Doma said Pacira has underserved its shareholders by raising management compensation and recording higher expenses as the stock has declined. Doma also called for the replacement of Pacira's CEO. \n\n\n  Pacira said its plans have the backing of its majority shareholders. \n\n\n  \"In our regular conversations with Pacira shareholders representing a majority of outstanding shares, we have heard clear support for our growth strategy,\" Pacira said. \n\n\n \n\n\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2026 17:43 ET (21:43 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}